Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811518) titled 'Latent Infection Freshmen Tracking for Tuberculosis' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: Affiliated Hospital of Nantong University

Condition: Latent Tuberculosis Infection (LTBI) Tuberculosis (TB)

Intervention: Drug: tuberculosis preventive treatment

Recruitment Status: Recruiting

Phase: Phase 4

Date of First Enrollment: August 15, 2022

Target Sample Size: 3000

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/stud...